Known targets — ChEMBL curated mechanism
KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2
The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 15/20 | 0.50 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3699875 | 0.94 | TLR7 (0.51) | TLR7TLR8 | |
| SCHEMBL853960 | 0.84 | NPSR1 (0.51) | TLR7TLR8 | |
| SCHEMBL16626811 | 0.83 | TLR7 (0.51) | TLR7TLR8 | |
| SCHEMBL854549 | 0.82 | TLR7 (0.47) | TLR7TLR8 | |
| Hydrochloric Acid SCHEMBL15391267 | 0.82 | TLR7 (0.51) | TLR7TLR8 | |
| SCHEMBL6119059 | 0.77 | FFAR1 (0.48) | TLR7 | |
| SCHEMBL3705863 | 0.77 | TLR7 (0.43) | TLR7DHFR | |
| SCHEMBL8547814 | 0.77 | TLR7 (0.43) | TLR7DHFR | |
| SCHEMBL19231007 | 0.77 | TLR7 (0.43) | TLR7TLR8 | |
| SCHEMBL3701040 | 0.76 | TLR7 (0.63) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432768-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES | AstraZeneca AB (SE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010133885-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | WO | disclosed |